Climb Bio (CLYM) Treasury Shares (2020 - 2026)

Climb Bio has reported Treasury Shares for 7 years, with the latest figure at $207775.0 in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares fell 77.13% year-over-year to $207775.0; the trailing twelve-month figure through Mar 2026 stood at $207775.0 (down 77.13% YoY), and the FY2025 full-year result was $207897.0, down 83.08% from the prior year.
• Treasury Shares for Q1 2026 stood at $207775.0, roughly flat from $207897.0 in the prior quarter.
• The five-year high for Treasury Shares was $1.2 million in Q3 2024, with the low at $149975.0 in Q4 2023.
• Historically, Treasury Shares has averaged $461140.7 across 5 years, with a median of $219310.0 in 2022.
• Annual changes were most pronounced in 2024 — Treasury Shares jumped 719.39% — and 2025, when it sank 83.38%.
• Climb Bio's Treasury Shares stood at $177495.0 in 2022, then dropped by 15.5% to $149975.0 in 2023, then jumped by 719.39% to $1.2 million in 2024, then slumped by 83.08% to $207897.0 in 2025, then fell by 0.06% to $207775.0 in 2026.
• The last three Treasury Shares figures came in at $207775.0 (Q1 2026), $207897.0 (Q4 2025), and $207375.0 (Q3 2025), per Business Quant data.